Short Term Effect on the Ocular Surface of a Liposome-Based Eye Spray in Dry Eye Disease.
- 1Department of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy.
Abstract
Purpose
Spray-based formulations have been proposed as an alternative approach for ocular surface treatment, particularly to improve ease of administration. However, limited data are available regarding their ability to reach and persist on the ocular surface when applied to closed eyelids.Patients and methods
This prospective, single-center study evaluated the presence and short-term persistence on the ocular surface of a liposome-based periocular spray in patients with dry eye disease. A total of 20 patients (40 eyes) were included. Tear film parameters were assessed using the Keratograph® 5M at baseline and at 15, 30, and 60 minutes after spray application. Outcome measures included non-invasive Keratograph break-up time (NIKBUT), tear meniscus height, bulbar conjunctival redness and patient-reported ocular discomfort.Results
NIKBUT values showed a significant increase at all post-application time points compared with baseline (p < 0.05), indicating improved tear film stability. Tear meniscus height exhibited a transient increase at 15 minutes (p < 0.05), returning toward baseline thereafter. No significant changes were observed in bulbar conjunctival redness. Subjective ocular discomfort scores significantly decreased following spray application (p < 0.05). No adverse events were reported.Conclusions
Periocular application of a liposome-based spray on closed eyelids resulted in measurable short-term improvements in tear film stability and patient-reported symptoms without inducing ocular surface irritation. These findings support the ability of this administration route to deliver functional effects on the ocular surface in patients with dry eye disease.
Related
- Severe Pediatric Ocular Surface Disease: Multimodal Approach and Treatment
- Yiguanjian alleviates ocular surface inflammation and lacrimal gland immune dysregulation in experimental dry eye disease: evidence from in vivo and in vitro models
- Associations between quantitative ocular surface features and CT morphology of the levator palpebrae superioris complex in patients with thyroid eye disease and upper eyelid retraction: a cross-sectional study
- Corneal Stiffening and Hyperosmolar Stress Associate With YAP1/TAZ Activation and Ocular Surface Inflammation in Dry Eye Disease.
- Paired longitudinal tear proteomics reveals persistent ocular surface dysregulation after teprotumumab therapy in thyroid eye disease
BibTeX
@article{palino2026short,
title = {{Short Term Effect on the Ocular Surface of a Liposome-Based Eye Spray in Dry Eye Disease.}},
author = {Paola Palino and Elisa Imelde Postorino and Alessia Scolaro and Marta Alberio and Enrico Tindaro Faustino and Maura Mancini and Pasquale Aragona},
journal = {Clinical ophthalmology (Auckland, N.Z.)},
year = {2026},
month = oct,
doi = {10.2147/opth.s624184},
url = {https://europepmc.org/article/MED/42921186},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Short Term Effect on the Ocular Surface of a Liposome-Based Eye Spray in Dry Eye Disease.
AU - Paola Palino
AU - Elisa Imelde Postorino
AU - Alessia Scolaro
AU - Marta Alberio
AU - Enrico Tindaro Faustino
AU - Maura Mancini
AU - Pasquale Aragona
PY - 2026
DA - 2026/10/19
JO - Clinical ophthalmology (Auckland, N.Z.)
DO - 10.2147/opth.s624184
UR - https://europepmc.org/article/MED/42921186
AB - Purpose Spray-based formulations have been proposed as an alternative approach for ocular surface treatment, particularly to improve ease of administration. However, limited data are available regarding their ability to reach and persist on the ocular surface when applied to closed eyelids.Patients and methods This prospective, single-center study evaluated the presence and short-term persistence on the ocular surface of a liposome-based periocular spray in patients with dry eye disease. A total of 20 patients (40 eyes) were included. Tear film parameters were assessed using the Keratograph® 5M at baseline and at 15, 30, and 60 minutes after spray application. Outcome measures included non-invasive Keratograph break-up time (NIKBUT), tear meniscus height, bulbar conjunctival redness and patient-reported ocular discomfort.Results NIKBUT values showed a significant increase at all post-application time points compared with baseline (p < 0.05), indicating improved tear film stability. Tear meniscus height exhibited a transient increase at 15 minutes (p < 0.05), returning toward baseline thereafter. No significant changes were observed in bulbar conjunctival redness. Subjective ocular discomfort scores significantly decreased following spray application (p < 0.05). No adverse events were reported.Conclusions Periocular application of a liposome-based spray on closed eyelids resulted in measurable short-term improvements in tear film stability and patient-reported symptoms without inducing ocular surface irritation. These findings support the ability of this administration route to deliver functional effects on the ocular surface in patients with dry eye disease.
SN - 1177-5467
SN - 1177-5483
ER -